News-Medical.NetMolecular engineered low-cost highly effective RBD-based COVID vaccineSep 19, 2022Pooja Toshniwal PahariaBy Pooja Toshniwal Pahariabookmark_bordersharemore_vert
Nature.comEngineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadthSep 22, 2022Xuping Xie, Hongjie Xia & Xiaohua YeBy Xuping Xie, Hongjie Xia & Xiaohua Yebookmark_bordersharemore_vert
Nature.comTracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021 | Scientific ReportsSep 21, 2022Eric Bortz & Ian GoodfellowBy Eric Bortz & Ian Goodfellowbookmark_bordersharemore_vert
Nature.comMagnitude of venous or capillary blood-derived SARS-CoV-2-specific T cell response determines COVID-19 immunitySep 21, 2022Awen Gallimore, Richard J Stanton & Lorenzo CapitaniBy Awen Gallimore, Richard J Stanton & Lorenzo Capitanibookmark_bordersharemore_vert